FDA Panel Backs Entresto, Spironolactone for Broader HF Use

(MedPage Today) -- After two days of deliberation on what could become the first approved drugs for heart failure with preserved ejection fraction (HFpEF), FDA advisors voted in favor of both--but not for HFpEF exactly.
Rather, members of...